Abstract
Due to the presence of the blood brain barrier (BBB) and the intrinsic complex structure of brain, there are several challenges to overcome in the treatment of brain diseases, for both diagnosis and targeting. The advancement of fast-growing nanotechnology provides many novel tools and creative ideas that can be used to solve these challenges. In the past decades, nanoparticles have been successfully employed as carriers for targeting drug delivery. The nanoparticles can deliver magnetic/imaging agent or a drug molecule specifically to the target site with a much higher concentration, and thus improve the efficiency of detection and treatment of the disease than traditional methods. Recently, the application of magnetic nanoparticles for diagnosis and targeting in brain has attracted significant attention. Many breakthroughs in this field have been demonstrated, and new inspiring conceptual ideas have been proposed. This review describes recent exciting advancements in magnetic nanoparticle based diagnosis and targeting drug delivery for the treatment of brain diseases. The mechanisms of magnetic nanoparticles-assisted diagnosis are discussed as well as the advantages of using nanoparticlesbased approaches for targeting drug delivery through brain barrier.
Keywords: Magnetic nanoparticles, Brain disease, MRI, Targeting drug delivery, Huntington's disease, Alzheimer's, Parkinson's disease, Mag-netic resonance imaging (MRI), Single Photon Emission Computed Tomo-graphy (SPECT), Positron Emission Tomography (PET), Computed Tomography (CT), Diffuse Optical Tomography, infrared light, radiation therapy, photody-namic therapy, bacteria, hydrophilic molecules, monocrystalline iron oxide nanoparticles, gadolinium-loaded polymer nanoparticles, Salmonella typhi, Herpes simplex virus, chemical vapor deposition, heparin, endothelial cells, transferrin receptor, chlorotoxin
Current Nanoscience
Title: Magnetic Nanoparticles in Brain Disease Diagnosis and Targeting Drug Delivery
Volume: 7 Issue: 1
Author(s): Xin Su, Xin Zhan, Fang Tang, Jingyuan Yao and Ji Wu
Affiliation:
Keywords: Magnetic nanoparticles, Brain disease, MRI, Targeting drug delivery, Huntington's disease, Alzheimer's, Parkinson's disease, Mag-netic resonance imaging (MRI), Single Photon Emission Computed Tomo-graphy (SPECT), Positron Emission Tomography (PET), Computed Tomography (CT), Diffuse Optical Tomography, infrared light, radiation therapy, photody-namic therapy, bacteria, hydrophilic molecules, monocrystalline iron oxide nanoparticles, gadolinium-loaded polymer nanoparticles, Salmonella typhi, Herpes simplex virus, chemical vapor deposition, heparin, endothelial cells, transferrin receptor, chlorotoxin
Abstract: Due to the presence of the blood brain barrier (BBB) and the intrinsic complex structure of brain, there are several challenges to overcome in the treatment of brain diseases, for both diagnosis and targeting. The advancement of fast-growing nanotechnology provides many novel tools and creative ideas that can be used to solve these challenges. In the past decades, nanoparticles have been successfully employed as carriers for targeting drug delivery. The nanoparticles can deliver magnetic/imaging agent or a drug molecule specifically to the target site with a much higher concentration, and thus improve the efficiency of detection and treatment of the disease than traditional methods. Recently, the application of magnetic nanoparticles for diagnosis and targeting in brain has attracted significant attention. Many breakthroughs in this field have been demonstrated, and new inspiring conceptual ideas have been proposed. This review describes recent exciting advancements in magnetic nanoparticle based diagnosis and targeting drug delivery for the treatment of brain diseases. The mechanisms of magnetic nanoparticles-assisted diagnosis are discussed as well as the advantages of using nanoparticlesbased approaches for targeting drug delivery through brain barrier.
Export Options
About this article
Cite this article as:
Su Xin, Zhan Xin, Tang Fang, Yao Jingyuan and Wu Ji, Magnetic Nanoparticles in Brain Disease Diagnosis and Targeting Drug Delivery, Current Nanoscience 2011; 7 (1) . https://dx.doi.org/10.2174/157341311794480363
DOI https://dx.doi.org/10.2174/157341311794480363 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke
Current Pharmaceutical Design Cytomegalovirus Infection in Pediatric Immunocompromised Hosts
Infectious Disorders - Drug Targets Depsipeptide (FK228) as a Novel Histone Deacetylase Inhibitor: Mechanism of Action and Anticancer Activity
Mini-Reviews in Medicinal Chemistry Novel Vitreous Modulators for Pharmacologic Vitreolysis in the Treatment of Diabetic Retinopathy
Current Pharmaceutical Biotechnology Research Progress on the Mechanisms of Combined Bevacizumab and Radiotherapy
Recent Patents on Anti-Cancer Drug Discovery Chemoprevention of Breast Cancer by Dietary Compounds
Anti-Cancer Agents in Medicinal Chemistry Intestinal Barrier Dysfunction in Human Pathology and Aging
Current Pharmaceutical Design Psychosocial Implications During Adolescence for Infant Heart Transplant Recipients
Current Cardiology Reviews Ouabain-Induced Signaling and Cell Survival in SK-N-SH Neuroblastoma Cells Differentiated by Retinoic Acid
CNS & Neurological Disorders - Drug Targets Adiponectin in Asthma: Implications for Phenotyping
Current Protein & Peptide Science Preface
Current Genomics Entrectinib: A New Selective Tyrosine Kinase Inhibitor Approved for the Treatment of Pediatric and Adult Patients with NTRK Fusionpositive, Recurrent or Advanced Solid Tumors
Current Medicinal Chemistry Inflammation and Chronic Oxidative Stress in Radiation-Induced Late Normal Tissue Injury: Therapeutic Implications
Current Medicinal Chemistry Biodefense Properties of Milk: The Role of Antimicrobial Proteins and Peptides
Current Pharmaceutical Design Investigation of Image Processing Techniques in MRI Based Medical Image Analysis Methods and Validation Metrics for Brain Tumor
Current Medical Imaging Vasoactive Factors and Diabetic Retinopathy: Vascular Endothelial Growth Factor, Cycoloxygenase-2 and Nitric Oxide
Current Pharmaceutical Design Transcranial Magnetic Stimulation of Degenerating Brain: A Comparison of Normal Aging, Alzheimer’s, Parkinson’s and Huntington's Disease
Current Alzheimer Research Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents
Current Medicinal Chemistry Increasing Testosterone Levels and Effects on Cognitive Functions in Elderly Men and Women: A Review
Current Drug Targets - CNS & Neurological Disorders Cancer Stem Cells in Hematological Disorders: Current and Possible New Therapeutic Approaches
Current Pharmaceutical Biotechnology